期刊文献+

Modification of the alkylating agent chlorambucil with spiropiperazinium salts

螺环季铵盐修饰的苯丁酸氮芥类抗肿瘤化合物(英文)
原文传递
导出
摘要 In order to improve the antitumor activity and reduce the toxicity of the alkylating agent chlorambucil, a series of spiropiperazinium salts of chlorambucil (8) were designed and synthesized. It was found that compound 8f exhibited potential in vivo activity against H22. 本文合成了一系列苯丁酸氮芥季铵盐类抗肿瘤化合物8a-8f,并对其抗肿瘤活性进行了初步测试。结果显示:化合物8f的体内抗H_(22)活性最强,优于阳性对照药苯丁酸氮芥。文中所揭示的构效关系,对进一步结构优化具有一定的指导意义。
出处 《Journal of Chinese Pharmaceutical Sciences》 CAS 2010年第5期346-352,共7页 中国药学(英文版)
基金 National Natural Science Foundation of China (Grant No.20472008) Fund for Young Teachers of School of Pharmaceutical Sciences,Peking University
关键词 CHLORAMBUCIL Antitumor activity Spiropiperazinium SAR 苯丁酸氮芥 抗肿瘤活性 螺环季铵盐 SAR
  • 相关文献

参考文献11

  • 1Huang, Z.H.; Yang, G.J.; Lin, H.L.; Huang, J.L. Bioorg. Med. Chem. Lett. 2001, 11, 1099-1103.
  • 2Jina, G.Z.; Youb, Y.J.; Kimb, Y.; Namb, N.H.; Ahnb, B.Z. Eur. J. Med. Chem. 2001, 36, 361-366.
  • 3Coggiola, B.; Pagliai, F.; Allegrone, G.; Genazzani, A.A.; Tron, G.C. Bioorg. Med. Chem. Lett. 2005, 15, 3551- 3554.
  • 4Gupta, A.; Saha, P.; Descoteaux, C.; Leblanc, V.; Asselin, E.; Berube, G. Bioorg. Med. Chem. Lett. 2010, 20, 1614-- 1618.
  • 5Reux, B.; Weber, V.; Galmier, M.J.; Borcl, M.; Madesclaire, M.; Madelmont, J.C.; Debiton, E.; Coudert, P. Bioorg. Med. Chem. 2008, 16, 5004--5020.
  • 6Halmos, T.; Santarromana, M.; Antonakis, K.; Scherman, D. Eur. J. Pharmacol. 1996, 318, 477-484.
  • 7Giraud, I.; Rapp, M.; Maurizis, J.C.; Madelmont, J.C. J. Med. Chem. 2002, 45, 2116-2119.
  • 8Sun, Q.; Li, R.T.; Guo, W.; Cui, J.R.; Cheng, T.M.; Ge, Z.M, Bioorg. Med. Chem. Lett. 2006, 16, 3727-3730.
  • 9Yang, Q.; Zhu, J.R.; Sun, Q.; Cui, J.R.; Li, R.T.; Ge, Z.M. J. Chin. Pharm. Sci. 2010, 19, 24-33.
  • 10Pang, L.P.; Huang, W.; Sun, Q.; Guo, W.; Li, R.T.; Cui, J.R. Anti. Cancer Drugs. 2008, 19, 167-174.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部